TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 7.61%199.2M | 22.09%548.69M | -19.52%185.11M | -27.93%449.4M | -21.52%230.02M | 17.07%623.58M | 32.39%293.1M | -4.98%532.67M | -12.45%221.39M | -5.33%560.59M |
Operating income | 7.61%199.2M | 22.09%548.69M | -19.52%185.11M | -27.93%449.4M | -21.52%230.02M | 17.07%623.58M | 32.39%293.1M | -4.98%532.67M | -12.45%221.39M | -5.33%560.59M |
Cost of sales | 12.81%-155.73M | -29.63%-460.34M | -0.32%-178.62M | 31.04%-355.12M | 25.69%-178.04M | -28.87%-515M | -44.96%-239.57M | 2.24%-399.63M | 14.73%-165.27M | 10.27%-408.8M |
Operating expenses | 12.81%-155.73M | -29.63%-460.34M | -0.32%-178.62M | 31.04%-355.12M | 25.69%-178.04M | -28.87%-515M | -44.96%-239.57M | 2.24%-399.63M | 14.73%-165.27M | 10.27%-408.8M |
Gross profit | 569.05%43.47M | -6.30%88.35M | -87.50%6.5M | -13.16%94.29M | -2.89%51.98M | -18.39%108.58M | -4.63%53.52M | -12.34%133.05M | -5.00%56.12M | 11.12%151.79M |
Selling expenses | 22.42%-12.68M | -9.26%-36.8M | -5.12%-16.34M | -6.19%-33.68M | -11.60%-15.55M | -17.12%-31.71M | -7.55%-13.93M | 22.25%-27.08M | 2.78%-12.95M | -16.93%-34.83M |
Administrative expenses | 6.45%-57.08M | 14.30%-121.69M | 17.97%-61.01M | -7.42%-142M | -18.19%-74.38M | -10.39%-132.19M | -6.81%-62.93M | -8.89%-119.75M | -8.64%-58.92M | -4.65%-109.97M |
Impairment and provision | -108.00%-8K | 39.87%-345.63K | 2.04%100K | -118.02%-574.83K | -96.07%98K | 109.56%3.19M | 152.01%2.49M | -584.96%-33.36M | -1,146.51%-4.79M | 57.29%-4.87M |
-Other impairment is provision | -108.00%-8K | 39.87%-345.63K | 2.04%100K | -118.02%-574.83K | -96.07%98K | 109.56%3.19M | 152.01%2.49M | -584.96%-33.36M | -1,146.51%-4.79M | 57.29%-4.87M |
Operating interest expense | ---- | ---- | ---- | ---- | ---- | 26.62%-3.58M | ---- | 17.61%-4.88M | ---- | -91.10%-5.92M |
Special items of operating profit | -693.71%-13.5M | -104.64%-3.7M | -97.17%2.27M | 81.63%79.86M | 141.89%80.42M | 220.72%43.97M | 219.70%33.25M | -107.36%-36.42M | -575.42%-27.77M | -14.33%-17.56M |
Operating profit | 41.90%-39.79M | -3,415.04%-74.19M | -260.88%-68.49M | 82.04%-2.11M | 243.27%42.57M | 86.72%-11.75M | 125.66%12.4M | -313.88%-88.43M | -2,111.40%-48.32M | 24.05%-21.37M |
Financing income | 19.23%3.4M | ---- | 1,451.63%2.86M | ---- | -60.68%184K | ---- | -28.44%468K | ---- | -3.11%654K | ---- |
Financing cost | 3.52%-3.15M | -61.74%-6.53M | -86.67%-3.26M | ---4.03M | 11.58%-1.75M | ---- | 29.17%-1.98M | ---- | 0.53%-2.79M | ---- |
Share of profit from joint venture company | ---- | 0.00%-3.75K | ---- | 0.00%-3.75K | ---- | 6.25%-3.75K | ---- | 56.84%-4K | ---- | -23.28%-9.27K |
Special items of earning before tax | ---- | 446.82%6M | ---- | --1.1M | ---- | ---- | ---- | ---- | ---- | ---- |
Earning before tax | 42.62%-39.53M | -1,379.14%-74.72M | -268.01%-68.89M | 57.02%-5.05M | 276.47%41.01M | 86.71%-11.75M | 121.59%10.89M | -313.72%-88.44M | -1,069.05%-50.46M | 24.04%-21.38M |
Tax | -104.98%-575K | -377.54%-7.36M | 510.96%11.55M | 329.06%2.65M | -0.72%-2.81M | -44.92%617.66K | -1,376.19%-2.79M | 118.76%1.12M | -112.76%-189K | -99.03%-5.98M |
After-tax profit from continuing operations | 30.06%-40.11M | -3,317.94%-82.07M | -250.14%-57.35M | 78.43%-2.4M | 371.43%38.2M | 87.25%-11.13M | 116.00%8.1M | -219.19%-87.32M | -1,686.42%-50.65M | 12.17%-27.36M |
After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 48.91%-3.62M |
Earning after tax | 30.06%-40.11M | -3,317.94%-82.07M | -250.14%-57.35M | 78.43%-2.4M | 371.43%38.2M | 87.25%-11.13M | 116.00%8.1M | -181.91%-87.32M | -717.91%-50.65M | 18.97%-30.97M |
Minority shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---190.8K |
Minority profit | 8.62%-53K | 75.93%-110.46K | -7.41%-58K | -7.13%-458.99K | -14.89%-54K | -229.71%-428.44K | 27.69%-47K | 31.89%-129.94K | 40.37%-65K | 36.81%-190.8K |
Shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 11.92%-27.17M |
Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 48.91%-3.62M |
Profit attributable to shareholders | 30.08%-40.06M | -4,119.97%-81.96M | -249.77%-57.29M | 81.86%-1.94M | 369.37%38.25M | 87.72%-10.71M | 116.11%8.15M | -183.24%-87.19M | -731.50%-50.58M | 18.83%-30.78M |
Basic earnings per share | 30.09%-0.158 | -4,101.30%-0.3235 | -249.67%-0.226 | 81.75%-0.0077 | 371.88%0.151 | 87.72%-0.0422 | 116.08%0.032 | -183.11%-0.3437 | -729.17%-0.199 | 18.80%-0.1214 |
Diluted earnings per share | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.